Directors' Shareholding

15th Dec 2009 08:12

Press Release 15 December 2009 Verona Pharma plc ("Verona" or the "Company") Director's Shareholding

Verona Pharma plc (AIM:VRP.L), the AIM quoted drug discovery company, announces that Magic Bullets Enterprises Ltd ("MBE"), a company controlled by Michael Walker, Chief Executive Officer of Verona, and Clive Page, Chairman of Verona, has on 10 December 2009, acquired 350,000 ordinary shares of 0.1p each in the Company ("Shares") at an average price of 13.89p per Share.

Following this acquisition, MBE has 350,000 Shares in Verona, representing 0.2 per cent. of the Company's issued share capital.

Following this acquisition, Mr. Walker, together with his wife, had a total interest of 5,912,768 Shares, representing 2.7 per cent. of the Company's issued share capital; whilst Mr. Page together with his wife, had a total interest of 5,784,621 Shares, representing 2.7 per cent. of the Company's issued share capital.

- Ends - For further information:EnquiriesProfessor Clive Page 020 7863 3300 Chairman, Verona Pharma plc Barry Saint / Tim Redfern / Esther Lee 020 7071 4300 Evolution Securities Limited Suzanne Johnson-Walsh / Gemma O'Hara 020 7562 3350

Bishopsgate Communications

vendor

---

Related Shares:

VRP.L